Product Details

Atectura Breezhaler

Indacaterol Acetate + Mometasone Furoate
150 mcg + 320 mcg
Powder for Inhalation
Capsule

DIN/PIN/NPN

02498693

Manufacturer

Novartis Pharma Canada Inc.

Formulary Listing Date

2022-02-28  

Unit Price

1.8473

Amount MOH Pays

1.8473

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

R03AK14

Interchangeable Products

NO  

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
626 Indefinite

For once-daily maintenance treatment of asthma in patients aged 12 years and older with reversible obstructive airways disease

 

EAP Criteria

NO

Product Monograph

View Monograph